Target intelligence / Profile preview

COL15A1 antisense RNA 1 (COL15A1-AS1)

Target
COL15A1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

COL15A1 antisense RNA 1 (COL15A1-AS1) is a long non-coding antisense RNA transcribed in the antisense direction at the COL15A1 gene locus. Like other lncRNAs, antisense transcripts can regulate the expression of their sense gene—in this case, potentially modulating the expression or function of the COL15A1 gene, which encodes collagen type XV α1 chain and is implicated in extracellular matrix organization and tissue homeostasis. lncRNAs of this class act via a range of mechanisms including transcriptional interference, recruitment of chromatin modifiers, or altering mRNA stability or translation, though the precise function of COL15A1-AS1 remains to be clarified. There is currently no evidence that COL15A1-AS1 itself is a therapeutic target, has a disease association, or is directly actionable by small molecules or biologics. Key points: - COL15A1-AS1 is a lncRNA, not a protein, receptor, or conventional drug target. - It likely plays a regulatory role at the RNA level, potentially affecting the function of the COL15A1 gene. - There is little to no specific information on its clinical or pharmacological significance at this time.

Other names
AL136084.3
02

Mechanism of action

Not applicable for direct drug targeting. General mechanisms for targeting lncRNAs include: Use of antisense oligonucleotides to mediate RNA degradation or translation inhibition.

03

Biological functions

Regulation of gene expression (at transcriptional, post-transcriptional, and epigenetic levels)Possible cis-regulation of the neighboring COL15A1 genePotential involvement in various cellular processes via modulation of mRNA stability or translation
04

Disease associations

No specific disease associations reported for COL15A1-AS1 in available scientific sources. As a lncRNA, it may be implicated in regulatory networks affecting diseases, especially those involving the COL15A1 locus.
05

Safety considerations

Not reported due to lack of targeted therapeutics and research.
06

Interacting drugs

No known drugs directly target COL15A1-AS1. Generic classes of drugs (e.g., antisense oligonucleotides) can theoretically target lncRNAs, but no specific therapeutics for COL15A1-AS1 are documented.
07

Biomarkers

No reported use of COL15A1-AS1 as a biomarker.

Beyond the preview

Go deeper on COL15A1 antisense RNA 1 (COL15A1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COL15A1 antisense RNA 1 (COL15A1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call